The US Food and Drug Administration approved, the first rapid-acting interchangeable biosimilar product, Kirsty (insulin ...

Sino Biopharmaceutical (HKEX: 1177) is acquiring the remaining stake in Chinese biotech LaNova Medicines, setting the stage ...

China-based Jiangsu Hengrui Pharma and US start-up Kailera Therapeutics, which is advancing a broad pipeline of ...

The USA's Institute for Clinical and Economic Review (ICER) has released a Final Evidence Report assessing the comparative ...

Russia will begin commercial production of a new anticancer vaccine, which massive supplies for the needs of domestic ...

US biotech Tract Bio has appointed Chris Galloway as chief medical and development officer, as it prepares for an ...

The Bristol Myers Squibb subsidiary RayzeBio has opened a new 77,000-square-foot facility in Indianapolis, Indiana.

In the USA, the 340B hospital markup program cost state and federal taxpayers an estimated $6.5 billion per year due to lost ...

USA-based Uniquity Bio has appointed industry veteran Will Kane as its president and chief executive. The clinical-stage drug ...

If approved, MCO-010 would be the first treatment to restore vision in legally blind RP patients without needing genetic ...

Swiss clinical-stage CNS disease specialist Synendos Therapeutics has named Dr George Garibaldi as its chief medical officer ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Ekterly (sebetralstat) 0for the ...